This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
A recent study found that combined tocilizumab and glucocorticoid therapy for at least 6 months did not fully eliminate vascular inflammation in patients with giant cell arteritis.
Medscape Medical News